These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12008299)

  • 1. Biosafety in the international context--the Cartagena protocol.
    Gaugitsch H
    Environ Sci Pollut Res Int; 2002; 9(2):95-6. PubMed ID: 12008299
    [No Abstract]   [Full Text] [Related]  

  • 2. Decision making under the Cartagena Protocol on Biosafety.
    Jank B; Gaugitsch H
    Trends Biotechnol; 2001 May; 19(5):194-7. PubMed ID: 11301133
    [No Abstract]   [Full Text] [Related]  

  • 3. The emerging international regulatory framework for biotechnology.
    Komen J
    GM Crops Food; 2012; 3(1):78-84. PubMed ID: 22430851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosafety rules get thumbs up.
    Hodgson J
    Nat Biotechnol; 2000 Mar; 18(3):253. PubMed ID: 10700125
    [No Abstract]   [Full Text] [Related]  

  • 5. UK government caught in GM dilemma.
    Mitchell P
    Nat Biotechnol; 2003 Sep; 21(9):957. PubMed ID: 12949540
    [No Abstract]   [Full Text] [Related]  

  • 6. The Cartagena protocol and GMOs.
    Pythoud F
    Nat Biotechnol; 2004 Nov; 22(11):1347-8. PubMed ID: 15529146
    [No Abstract]   [Full Text] [Related]  

  • 7. US animal biotech regulations "may not be adequate".
    Fox JL
    Nat Biotechnol; 2002 Oct; 20(10):959. PubMed ID: 12355099
    [No Abstract]   [Full Text] [Related]  

  • 8. New Zealand GMO incident highlights lack of standardized tests.
    Norrie C
    Nat Biotechnol; 2002 Sep; 20(9):861. PubMed ID: 12205493
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathways to security.
    Nature; 2008 Sep; 455(7212):432. PubMed ID: 18818599
    [No Abstract]   [Full Text] [Related]  

  • 10. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 11. Concern about Japan's unclear biotech regulations.
    Watanabe KN
    Nature; 2003 Feb; 421(6924):689. PubMed ID: 12610594
    [No Abstract]   [Full Text] [Related]  

  • 12. G-8 leaders fudge biotech position.
    Dorey E
    Nat Biotechnol; 2000 Sep; 18(9):923-4. PubMed ID: 10973204
    [No Abstract]   [Full Text] [Related]  

  • 13. Socioeconomics and the protocol on biosafety.
    Crompton T; Wakeford T
    Nat Biotechnol; 1998 Aug; 16(8):697-8. PubMed ID: 9702752
    [No Abstract]   [Full Text] [Related]  

  • 14. The science and politics of plant biotechnology--a personal perspective.
    Vasil IK
    Nat Biotechnol; 2003 Aug; 21(8):849-51. PubMed ID: 12894193
    [No Abstract]   [Full Text] [Related]  

  • 15. The biosafety protocol slouches toward Montreal.
    Hoyle R
    Nat Biotechnol; 1997 Aug; 15(8):694. PubMed ID: 9255771
    [No Abstract]   [Full Text] [Related]  

  • 16. USDA scrutinizes GM organism regulations.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):254-5. PubMed ID: 14990936
    [No Abstract]   [Full Text] [Related]  

  • 17. Switzerland. Compromise allows transgenic trials.
    Ku M
    Science; 2002 Oct; 298(5592):343. PubMed ID: 12376677
    [No Abstract]   [Full Text] [Related]  

  • 18. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cartagena Protocol and genetically modified mosquitoes.
    Marshall JM
    Nat Biotechnol; 2010 Sep; 28(9):896-7. PubMed ID: 20829820
    [No Abstract]   [Full Text] [Related]  

  • 20. Research and regulation on biosafety of GMOs in China.
    Jia S; Peng Y
    Environ Biosafety Res; 2003; 2(1):57-9. PubMed ID: 15615070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.